BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30877933)

  • 1. A UHPLC-MS/MS method coupled with simple and efficient alkaline hydrolysis for free and total determination of conjugate nanomedicine: Pharmacokinetic and biodistribution study of poly (l-glutamic acid)-graft-methoxy poly (ethylene glycol)/combretastatin A4.
    Zeng Q; Liu Y; Song Y; Feng B; Xu P; Shan B; Liao Z; Liu K; Zhong Y; Chen L; Su D
    J Pharm Biomed Anal; 2019 May; 169():215-224. PubMed ID: 30877933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A poly(l-glutamic acid)-combretastatin A4 conjugate for solid tumor therapy: Markedly improved therapeutic efficiency through its low tissue penetration in solid tumor.
    Liu T; Zhang D; Song W; Tang Z; Zhu J; Ma Z; Wang X; Chen X; Tong T
    Acta Biomater; 2017 Apr; 53():179-189. PubMed ID: 28167300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
    Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
    J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a rapid and sensitive LC-MS/MS assay for the determination of combretastatin A4 phosphate, combretastatin A4 and combretastatin A4 glucuronide in beagle dog plasma and its application to a pharmacokinetic study.
    Wang X; Chen Z; Che J; Meng Q; Shan C; Hou Y; Liu X; Chai Y; Cheng Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(30):3813-21. PubMed ID: 19822461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Amplifying Nanotherapeutic Drugs Homing to Tumors in a Manner of Chain Reaction.
    Wang Y; Shen N; Wang Y; Zhang Y; Tang Z; Chen X
    Adv Mater; 2021 Feb; 33(7):e2002094. PubMed ID: 33382144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(L-Glutamic Acid)-Drug Conjugates for Chemo- and Photodynamic Combination Therapy.
    Yu H; Bao Y; Xu C; Chen L; Tang Z
    Macromol Biosci; 2021 Jan; 21(1):e2000192. PubMed ID: 33043592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formula optimization and in vivo study of poly(L-glutamic acid)-g-methoxy poly(ethylene glycol)/combretastatin A4/BLZ945 nanoparticles for cancer therapy.
    Huang Y; Yang C; Lv J; Zhang Y; Wang K; Ma L; Liu Z; Yu H; Li M; Tang Z
    Int J Pharm; 2023 Apr; 636():122849. PubMed ID: 36933582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combretastatin A4/poly(
    Ou Y; Tang ZH; Sun L; Yu HY; Li J; Zhao MH; Xu H
    Asian J Pharm Sci; 2018 Mar; 13(2):191-196. PubMed ID: 32104392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3Kgamma Inhibitor Attenuates Immunosuppressive Effect of Poly(l-Glutamic Acid)-Combretastatin A4 Conjugate in Metastatic Breast Cancer.
    Qin H; Yu H; Sheng J; Zhang D; Shen N; Liu L; Tang Z; Chen X
    Adv Sci (Weinh); 2019 Jun; 6(12):1900327. PubMed ID: 31380170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-throughput and simultaneous determination of combretastatin A-4 phosphate and its metabolites in human plasma using HPLC-MS/MS: Application to a clinical pharmacokinetic study.
    Wu Q; Wang Q; Wang Y; Huang J; Fang Y; Wu W; Wu W; Wu F; Yu X; Sun Y
    Biomed Chromatogr; 2021 Nov; 35(11):e5204. PubMed ID: 34165810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity.
    Zhou H; Lv S; Zhang D; Deng M; Zhang X; Tang Z; Chen X
    Acta Biomater; 2018 Jun; 73():388-399. PubMed ID: 29694920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-administration of combretastatin A4 nanoparticles and sorafenib for systemic therapy of hepatocellular carcinoma.
    Wang Y; Yu H; Zhang D; Wang G; Song W; Liu Y; Ma S; Tang Z; Liu Z; Sakurai K; Chen X
    Acta Biomater; 2019 Jul; 92():229-240. PubMed ID: 31100462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, excretion, and distribution of combretastatin A4 phosphate in rats.
    Xu XP; Wu XD; Liang GL; Huang WS; Wang L; Jing HY; Zhong SL
    Pharmazie; 2012 Jun; 67(6):529-33. PubMed ID: 22822542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An eximious and affordable GSH stimulus-responsive poly(α-lipoic acid) nanocarrier bonding combretastatin A4 for tumor therapy.
    Liu Z; Shen N; Tang Z; Zhang D; Ma L; Yang C; Chen X
    Biomater Sci; 2019 Jun; 7(7):2803-2811. PubMed ID: 31062006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration of combretastatin A4 nanoparticles and anti-PD-L1 for synergistic therapy of hepatocellular carcinoma.
    Zhao B; Dong Z; Liu W; Lou F; Wang Q; Hong H; Wang Y
    J Nanobiotechnology; 2021 May; 19(1):124. PubMed ID: 33933077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy.
    Gu Y; Ma J; Fu Z; Xu Y; Gao B; Yao J; Xu W; Chu K; Chen J
    Int J Nanomedicine; 2019; 14():8805-8818. PubMed ID: 31806973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor regression and potentiation of polymeric vascular disrupting therapy through reprogramming of a hypoxia microenvironment with temsirolimus.
    Yu H; Shen N; Bao Y; Chen L; Tang Z
    Biomater Sci; 2020 Jan; 8(1):325-332. PubMed ID: 31714543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination and pharmacokinetic study of two triterpenoid saponins in rat plasma after oral administration of the extract of Aralia elata leaves by UHPLC-ESI-MS/MS.
    Wang Z; Wu Q; Meng Y; Sun Y; Wang Q; Yang C; Wang Q; Yang B; Kuang H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():164-71. PubMed ID: 25687802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of fourteen compounds of Hedyotis diffusa Willd extract in rats by UHPLC-MS/MS method: Application to pharmacokinetics and tissue distribution study.
    Chen X; Zhu P; Liu B; Wei L; Xu Y
    J Pharm Biomed Anal; 2018 Sep; 159():490-512. PubMed ID: 30048897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and Characterization Evaluation of Poly(L-Glutamic Acid)-
    Guo D; Huang Y; Wang K; Yang C; Ma L; Zhang Y; Yu H; Cui M; Tang Z
    Int J Nanomedicine; 2023; 18():6901-6914. PubMed ID: 38026524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.